Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002485992 | SCV002802869 | likely benign | Dent disease type 2; Lowe syndrome | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002570544 | SCV002929686 | likely benign | Lowe syndrome | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035334 | SCV004994494 | likely benign | Nephrolithiasis/nephrocalcinosis | 2023-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |